Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

News Conference News SCAI 2013

ACC/AHA/SCAI Statement: Volume Not the Sole Arbiter of Quality PCI

May 10, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.